+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Novel multiresistance cfr plasmids in linezolid-resistant methicillin-resistant Staphylococcus epidermidis and vancomycin-resistant Enterococcus faecium (VRE) from a hospital outbreak: co-location of cfr and optrA in VRE



Novel multiresistance cfr plasmids in linezolid-resistant methicillin-resistant Staphylococcus epidermidis and vancomycin-resistant Enterococcus faecium (VRE) from a hospital outbreak: co-location of cfr and optrA in VRE



Journal of Antimicrobial ChemoTherapy 72(12): 3252-3257



Linezolid is often the drug of last resort to treat infections caused by Gram-positive cocci. Linezolid resistance can be mutational (23S rRNA or L-protein) or, less commonly, acquired [predominantly cfr, conferring resistance to phenicols, lincosamides, oxazolidinones, pleuromutilins and streptogramin A compounds (PhLOPSA) or optrA, encoding oxazolidinone and phenicol resistance]. To investigate the clonality and genetic basis of linezolid resistance in 13 linezolid-resistant (LZDR) methicillin-resistant Staphylococcus epidermidis (MRSE) isolates recovered during a 2013/14 outbreak in an ICU in an Irish hospital and an LZDR vancomycin-resistant Enterococcus faecium (VRE) isolate from an LZDR-MRSE-positive patient. All isolates underwent PhLOPSA susceptibility testing, 23S rRNA sequencing, DNA microarray profiling and WGS. All isolates exhibited the PhLOPSA phenotype. The VRE harboured cfr and optrA on a novel 73 kb plasmid (pEF12-0805) also encoding erm(A), erm(B), lnu(B), lnu(E), aphA3 and aadE. One MRSE (M13/0451, from the same patient as the VRE) harboured cfr on a novel 8.5 kb plasmid (pSEM13-0451). The remaining 12 MRSE lacked cfr but exhibited linezolid resistance-associated mutations and were closely related to (1-52 SNPs) but distinct from M13/0451 (202-223 SNPs). Using WGS, novel and distinct cfr and cfr/optrA plasmids were identified in an MRSE and VRE isolate, respectively, as well as a cfr-negative LZDR-MRSE ICU outbreak and a distinct cfr-positive LZDR-MRSE from the same ICU. To our knowledge, this is the first report of cfr and optrA on a single VRE plasmid. Ongoing surveillance of linezolid resistance is essential to maintain its therapeutic efficacy.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 060029962

Download citation: RISBibTeXText

PMID: 28961986

DOI: 10.1093/jac/dkx292


Related references

Comparative in vitro activity of linezolid and five other antimicrobials against nosocomial isolates of methicillin-resistant Staphylococcus aureus, methicillin-resistant Staphylococcus epidermidis and vancomycin-resistant Enterococcus faecium. Journal of ChemoTherapy 15(5): 442-448, 2003

Comparison of Linezolid Activities under Aerobic and Anaerobic Conditions against Methicillin-Resistant Staphylococcus aureus and Vancomycin-Resistant Enterococcus faecium. Antimicrobial Agents and Chemotherapy 47(1): 398-399, 2003

Comparison of linezolid activities under aerobic and anaerobic conditions against methicillin-resistant Staphylococcus aureus and vancomycin-resistant Enterococcus faecium. Antimicrobial Agents and ChemoTherapy 47(1): 398-399, 2003

First outbreak of linezolid-resistant vancomycin-resistant Enterococcus faecium in an Irish hospital, February to September 2014. Journal of Hospital Infection 91(4): 367-370, 2015

Evaluation of the mutant prevention concentration of daptomycin, linezolid, and quinupristin-dalfopristin against methicillin- and glycopeptide-resistant Staphylococcus aureus and vancomycin-resistant Enterococcus faecium. Abstracts of the General Meeting of the American Society for Microbiology 101: 33, 2001

Activity of quinupristin/dalfopristin compared to linezolid in the treatment of vancomycin-resistant Enterococcus faecium and methicillin-resistant Staphylococcus aureus in experimental model of endocarditis in rabbits. Abstracts of the Interscience Conference on Antimicrobial Agents and Chemotherapy 41: 33, 2001

Hospital demographics and prevalence of methicillin-resistant Staphylococcus aureus and vancomycin-resistant Enterococcus faecium. Pharmacotherapy 22(10): 1349, 2002

Evaluation of the in vitro activities of quinupristin-dalfopristin , cefepime , linezolid , ampicillin , doxocycline , and vancomycin , alone and/or in combination against vancomycin-resistant Enterococcus faecalis and E faecium , methicillin-resistant Staphylococcus aureus , and glycopeptide intermediate-susceptible S aureus in an in vitro pharmacodynamic infection model IVPM. Abstracts of the Interscience Conference on Antimicrobial Agents and Chemotherapy 40: 183, 2000

Methicillin-resistant Staphylococcus aureus, vancomycin-resistant Enterococcus faecalis and Enterococcus faecium active dimeric isobutyrylphloroglucinol from Ivesia gordonii. Natural Product Communications 9(2): 221-224, 2014

In vitro susceptibility to linezolid in methicillin-resistant Staphylococcus aureus and vancomycin-resistant Enterococcus strains. Mikrobiyoloji Bulteni 43(4): 639-643, 2009

In vitro activity of a new glycopeptide, LY333328 alone and in combination with vancomycin , rifampin and gentamicin against methicillin-resistant Staphylococcus aureus and vancomycin-resistant Enterococcus faecium at standard and high inoculum. Abstracts of the Interscience Conference on Antimicrobial Agents and Chemotherapy 36: 136, 1996

Bactericidal activities of two daptomycin regimens against clinical strains of glycopeptide intermediate-resistant Staphylococcus aureus, vancomycin-resistant Enterococcus faecium, and methicillin-resistant Staphylococcus aureus isolates in an in vitro pharmacodynamic model with simulated endocardial vegetations. Antimicrobial Agents and ChemoTherapy 45(2): 454-459, 2001

In vitro antimicrobial activity of propolis against methicillin-resistant Staphylococcus aureus and vancomycin-resistant Enterococcus faecium. Annals of Microbiology 55(2): 113-117, 2005

In vitro susceptibility of methicillin-resistant Staphylococcus aureus and vancomycin-resistant Enterococcus faecium to daptomycin and other antibiotics. European Journal of Clinical Microbiology and Infectious Diseases 26(5): 363-365, 2007

In-vitro activities of five plant essential oils against methicillin- resistant Staphylococcus aureus and vancomycin-resistant Enterococcus faecium. Journal of Antimicrobial Chemotherapy 40(2): 305-306, 1997